Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $14.05B. Across the group, the median move over the past trading day is +2.09%. Price change over the past year runs from −8.6% to +235.1% across the middle 80 percent of the group, with a median of +40.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +50.53% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | −18.08% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.